Evaluation of melanin-related metabolites as markers of solar ultraviolet-B radiation

Pigment Cell Research

Volumn 19, Issue 5, 2006, Pages 460-464

  Wakamatsu, Kazumasa ^a   Ito, Shosuke ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

5 S Cysteinyldopa; 6 hydroxy 5 methoxyindole 2 carboxylic acid; Eumelanin; Sunlight; Ultraviolet radiation

Indexed keywords

6 HYDROXY 5 METHOXYINDOLE 2 CARBOXYLIC ACID; BIOCHEMICAL MARKER; CYSTEINYLDOPA; MELANIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD LEVEL; METABOLITE; SKIN INJURY; SKIN PIGMENTATION; ULTRAVIOLET RADIATION;

ADULT; BIOLOGICAL MARKERS; CYSTEINYLDOPA; FEMALE; HUMANS; INDOLES; MALE; MELANINS; MIDDLE AGED; SEASONS; SKIN; SKIN PIGMENTATION; ULTRAVIOLET RAYS;

EID: 33748334339     PISSN: 08935785     EISSN: 16000749     Source Type: Journal    
DOI: 10.1111/j.1600-0749.2006.00324.x     Document Type: Article

References (25)

1. Agrup, G., Hansson, C., Rorsman, C., Rosengren, A.-M., Rosengren, E., and Tegner, E. (1978). 5-S-cysteinyldopa excretion after treatment with 8-methoxypsoralen and UVA light. J. Invest. Dermatol. 70, 25-26.
2. Agrup, G., Agrup, P., Andersson, T., Hafström, L., Hansson, C., Jacobsson, S., Jönsson, P.-E., Rorsman, H., Rosengren, A.-M., and Rosengren, E. (1979). 5 yr' experience of 5-S-cysteinyldopa in melanoma diagnosis. Acta Derm. Venerol. 59, 381-388.
3. Ekelund, M.C., Carstam, R., Hannson, C., Rorsman, H., and Rosengren, E. (1985). Urinary excretion of 5-S-cysteinyldopa and 6-hydroxyindole-2-carboxylic acid: differences between pigmented and albino mice. Acta Derm. Venereol. 65, 437-439.
4. Hansson, C. (1988). Some indolic compounds as markers of the melanocyte activity. Acta Derm. Venereol. Suppl. 138, 1-60.
5. Hansson, C., Rorsman, H., Rosengren, E., and Tegner, T. (1981). 5-S-Cysteinyldopa and dopa in serum during treatment with 8-methoxypsoralen and UVA light. Acta Derm. Venereol. 61, 251-255.
6. Hearing, V.J. (1998). The regulation of melanin production. In The Pigmentary System. Physiology and Pathophysiology, J.J. Nordlund, R.E. Boissy, V.J. Hearing, R.A. King, J.-P. Ortonne, ed. (New York: Oxford University Press), pp. 423-438.
7. Ito, S. (2003). A chemist's view of melanogenesis. Pigment Cell Res. 16, 230-236.
8. Kågedal, B., Lenner, L., Årstrand, K., and Hansson, C. (1992). The stability of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2- carboxylic acid in human urine. Pigment Cell Res. 5 (Suppl. 2), 304-307.
9. Kärnell, R., Kågedal, B., Lindholm, C., Nilsson, B., Årstrand, K., and Ringborg, U. (2000). The value of cysteinyldopa in the follow-up of disseminated malignant melanoma. Melanoma Res. 10, 363-369.
10. Matsumura, Y., and Anathaswamy, H.N. (2004). Toxic effects of ultraviolet radiation on the skin. Toxicol. Appl. Pharmacol. 195, 298-308.
11. Meyerhöffer, S., Lindberg, Z., Häger, A., Kågedal, B., and Rosdahl, I. (1998). Urinary excretion of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in children. Acta Derm. Venereol. 78, 31-35.
12. Nimmo, J.E., Gawkrodger, D.J., O'Docherty, C.S.J., Going, S.M., Percy-Robb, I.W., and Hunter, J.A.A. (1988). Plasma 5-S-cysteinyldopa as an index of melanogenesis. Brit. J. Dermatol. 118, 487-496.
13. Rodgers, K.J., and Dean, R.T. (2000). Metabolism of protein-bound DOPA in mammals. Int. J. Biochem. Cell Biol. 32, 945-955.
14. Rorsman, H., Agrup, G., Falck, B., Rosengren, A.M., and Rosengren, E. (1976). Exposure to sunlight and urinary excretion of 5-S-cysteinyldopa. In Pigment Cell, Vol. 2, V. Riley, ed. (Basel: Karger), pp. 284-289.
15. Stierner, U. (1991). Melanocytes, moles and melanoma - a study on UV effects. Acta Derm Venereol. Suppl. 168, 1-31.
16. Stierner, U., Rosdahl, I., Augustsson, A., and Kågedal, B. (1988). Urinary excretion of 5-S-cysteinyldopa in relation to skin type, UVB-induced erythema, and melanocyte proliferation in human skin. J. Invest. Dermatol. 91, 506-510.
17. Tegner, E., Rorsman, H., and Rosengren, E. (1983). 5-S-Cysteinyldopa and pigment response to UVA light. Acta Derm. Venereol. 63, 21-25.
18. Wakamatsu, K., and Ito, S. (1990). Identification of ester glucuronide and sulfate conjugates of 5-hydroxy-6-methoxyindole-2-carboxylic acid and 6-hydroxy-5-methoxyindole-2-carboxylic acid in melanoma urine. J. Dermatol. Sci. 1, 253-260.
19. Wakamatsu, K., and Ito, S. (1994). Improved HPLC determination of 5-S-cysteinyldopa in serum. Clin. Chem. 40, 495-496.
20. Wakamatsu, K., and Ito, S. (1995). Seasonal variation in serum concentration of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in healthy Japanese. Pigment Cell Res. 8, 132-134.
21. Wakamatsu, K., Ito, S., and Fujita, K. (1990). Production, circulation, and excretion of melanin-related metabolites in B16 melanomabearing mice. Acta Derm. Venereol. 70, 367-372.
22. Wakamatsu, K., Ito, S., and Horikoshi, T. (1991). Normal values of urinary excretion and serum concentration of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid, biochemical markers of melanoma progression. Melanoma Res. 1, 141-147.
23. Wakamatsu, K., Kageshita, T., Furue, M. et al. (2002). Evaluation of 5-S-cysteinyldopa as a marker of melanoma progression: 10 yr' experience. Melanoma Res. 12, 245-253.
24. Westerhof, W., Pavel, S., Kammeyer, A., Beusenberg, F.D., and Cormane, R. (1987). Melanin-related metabolites as markers of the skin pigmentary system. J. Invest. Dermatol. 95, 78-81.
25. Wirestrand, L.-E., Hansson, C., Rosengren, E., and Rorsman, H. (1985). Melanocyte metabolites in the urine of people of different skin colour. Acta Derm. Venereol. 65, 345-348.